or Try an Advanced Search...

    Hepatitis B Virus Stocks List

    Symbol Grade Name % Change
    INO B Inovio Pharmaceuticals, Inc. 0.75
    HOOK B HOOKIPA Pharma Inc. 1.34
    VIR C Vir Biotechnology, Inc. 13.18
    ABUS D Arbutus Biopharma Corporation 1.12
    NTLA F Intellia Therapeutics, Inc. 1.42
    IONS F Ionis Pharmaceuticals, Inc. -2.60
    NNVC F NanoViricides, Inc. -5.83
    BMY F Bristol-Myers Squibb Company 0.66
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

    Symbol Grade Name Weight
    ARKG D ARK Genomic Revolution Multi-Sector ETF 8.25
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 7.16
    MEDX F Horizon Kinetics Medical ETF 5.43
    WBIY D WBI Power Factor High Dividend ETF 4.72
    GNOM D Global X Genomics & Biotechnology ETF 4.43
    View all Hepatitis B Virus ETFs...
    Compare ETFs
    Compare ARKG to MEDX Compare ARKG to WBIY Compare MEDX to WBIY

        Hepatitis B Virus Stocks Recent News

        Date Stock Title
        May 3 VIR Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript
        May 3 VIR Vir Biotechnology Provides Some Hope For Its Beleaguered Shareholders
        May 3 ABUS Arbutus Biopharma Corporation (NASDAQ:ABUS) Q1 2024 Earnings Call Transcript
        May 3 NTLA IGM Biosciences, Inc. (IGMS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
        May 3 BMY Could Investing $100,000 in Bristol Myers Squibb Stock Make You a Millionaire?
        May 3 BMY If You'd Invested $1,000 in Bristol Myers Squibb 5 Years Ago, Here's How Much You'd Have Today
        May 3 ABUS Arbutus Biopharma First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        May 3 VIR Q1 2024 Vir Biotechnology Inc Earnings Call
        May 3 BMY The Zacks Analyst Blog Highlights Gilead Sciences, GSK, Deciphera, Bristol Myers and Editas Medicine
        May 3 VIR Vir Biotechnology Inc (VIR) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...
        May 3 ABUS Arbutus Biopharma Corp (ABUS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
        May 3 VIR Vir Biotechnology, Inc. (VIR) Q1 2024 Earnings Call Transcript
        May 3 BMY Bristol-Myers Squibb: A Lost Decade?
        May 2 VIR Vir Biotechnology, Inc. (VIR) Reports Q1 Loss, Tops Revenue Estimates
        May 2 VIR Vir Biotechnology GAAP EPS of -$0.48 beats by $0.59, revenue of $56.38M beats by $44.67M
        May 2 VIR Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
        May 2 BMY Schrodinger gets rights to cancer drug candidate back from Bristol
        May 2 ABUS Arbutus Biopharma Corporation (ABUS) Q1 2024 Earnings Call Transcript
        May 2 BMY Biotech Stock Roundup: GILD's GSK' Q1 Earnings, DCPH Soars on Acquisition News & More
        May 2 ABUS Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection
        Hepatitis B Virus

        Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

        More about Hepatitis B Virus
        Browse All Tags